Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Siebers AG et al. – This study indicates that liquid-based cytology does not perform better than conventional Pap tests in terms of relative sensitivity and PPV for detection of cervical cancer precursors.
Methods- Cluster randomized controlled trial involving 89 784 women aged 30 to 60 years participating in Dutch cervical screening program at 246 family practices
- 122 practices were assigned to use liquid-based cytology and screened 49 222 patients and 124 practices were assigned to use the conventional Papanicolaou (Pap) test and screened 40 562 patients between April 2004 and July 1, 2006
- Patients followed up for 18 months through January 31, 2008
- Adjusted detection rate ratios for CIN grade 1+ was 1.01 ; for CIN grade 2+, 1.00 ; for CIN grade 3+, 1.05 ; and for carcinoma, 1.69
- Adjusted positive predictive value (PPV) ratios, considered at several cytological cutoffs and for various outcomes of CIN did not differ significantly from unity
Today in Diagnostics/Radiology...keeping you current
Receive free subspecialty "5-minute updates" via email
Hodgkin's lymphoma in remission after first-line therapy: Which patients need FDG-PET/CT for follow-up?
Annals of Oncology, 11/17/09
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Ovarian cancer screening and early detection
Women's Health, 11/04/09
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: A phase 3, open-label, randomised controlled trial
The Lancet, 11/23/09
Vaccination against HPV-16 oncoproteins for vulvar intraepithelial neoplasia
New England Journal of Medicine, 11/06/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


